Knowledge and behavior of consumers towards the non-prescription purchase of antibiotics: An insight from a qualitative study from New Delhi, India.
Anti-Bacterial Agents
Bacterial
Commerce
Developing Countries
Drug Resistance
Evidence-Based Practice
India
Nonprescription Drugs
Pharmacies
Pharmacists
Prescriptions
Public Health
Qualitative Research
Self Medication
Journal
Pharmacy practice
ISSN: 1885-642X
Titre abrégé: Pharm Pract (Granada)
Pays: Spain
ID NLM: 101530029
Informations de publication
Date de publication:
Historique:
received:
26
10
2020
accepted:
21
03
2021
entrez:
8
4
2021
pubmed:
9
4
2021
medline:
9
4
2021
Statut:
ppublish
Résumé
In Low-and Middle-Income Countries, including India, consumers often purchase antibiotics over-the-counter (OTC) from retail pharmacies. This practice leads to the inappropriate use of antibiotics in the community which is an important driver for the development of antimicrobial resistance. A better understanding of consumers' views towards this grave public health concern is critical to developing evidence-based intervention programs for awareness among the general population. To explore knowledge, practice and, behavior of consumers towards antibiotics, antibiotic use, antimicrobial resistance, purchasing behavior of consumers for antibiotics, and to gain insight which will help in developing evidence-based policy interventions. 72 in-depth consumer interviews were conducted in all 11 districts of the National Capital Territory of Delhi. The qualitative data were analyzed using thematic analysis. Our study found that retail pharmacies were the first point of consultation for common ailments for patients/consumers once home remedies failed; they were largely unaware of the threat of antimicrobial resistance. Consumers' knowledge of antibiotic use and about antimicrobial resistance was low, they used old prescriptions, and bought antibiotics OTC to save time and money. Despite the presence of regulations constituted to regulate the sale of antibiotics by the Government and the implementation of national campaigns, the practice of self-medication and behaviors such as OTC purchase, non-adherence to prescribed antibiotics was prevalent. Consumers perceive that antibiotics provide quick relief and accelerate the curing process and retail pharmacy shops try to protect their retail business interests by honoring old prescriptions and self-medication for antibiotics. The lack of awareness and insufficient knowledge about what antibiotics are and issues such as antimicrobial resistance or antibiotic resistance resulted in misuse of antibiotics by consumers. Limited access to public healthcare and affordability of private healthcare are factors that contribute towards the self-medication/OTC purchase of antibiotics. The regular misuse of antibiotics through irrational use reinforces the need for strong enactment of strategies like continuous community awareness campaigns. Mitigation efforts should focus upon educating consumers continuously and sustainably for the understanding of antibiotic misuse, antimicrobial resistance, and promote better compliance with regulations.
Sections du résumé
BACKGROUND
BACKGROUND
In Low-and Middle-Income Countries, including India, consumers often purchase antibiotics over-the-counter (OTC) from retail pharmacies. This practice leads to the inappropriate use of antibiotics in the community which is an important driver for the development of antimicrobial resistance. A better understanding of consumers' views towards this grave public health concern is critical to developing evidence-based intervention programs for awareness among the general population.
OBJECTIVE
OBJECTIVE
To explore knowledge, practice and, behavior of consumers towards antibiotics, antibiotic use, antimicrobial resistance, purchasing behavior of consumers for antibiotics, and to gain insight which will help in developing evidence-based policy interventions.
METHODS
METHODS
72 in-depth consumer interviews were conducted in all 11 districts of the National Capital Territory of Delhi. The qualitative data were analyzed using thematic analysis.
RESULTS
RESULTS
Our study found that retail pharmacies were the first point of consultation for common ailments for patients/consumers once home remedies failed; they were largely unaware of the threat of antimicrobial resistance. Consumers' knowledge of antibiotic use and about antimicrobial resistance was low, they used old prescriptions, and bought antibiotics OTC to save time and money. Despite the presence of regulations constituted to regulate the sale of antibiotics by the Government and the implementation of national campaigns, the practice of self-medication and behaviors such as OTC purchase, non-adherence to prescribed antibiotics was prevalent. Consumers perceive that antibiotics provide quick relief and accelerate the curing process and retail pharmacy shops try to protect their retail business interests by honoring old prescriptions and self-medication for antibiotics.
CONCLUSIONS
CONCLUSIONS
The lack of awareness and insufficient knowledge about what antibiotics are and issues such as antimicrobial resistance or antibiotic resistance resulted in misuse of antibiotics by consumers. Limited access to public healthcare and affordability of private healthcare are factors that contribute towards the self-medication/OTC purchase of antibiotics. The regular misuse of antibiotics through irrational use reinforces the need for strong enactment of strategies like continuous community awareness campaigns. Mitigation efforts should focus upon educating consumers continuously and sustainably for the understanding of antibiotic misuse, antimicrobial resistance, and promote better compliance with regulations.
Identifiants
pubmed: 33828621
doi: 10.18549/PharmPract.2021.1.2206
pii: pharmpract-19-2206
pmc: PMC8005328
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2206Informations de copyright
Copyright: © Pharmacy Practice and the Authors.
Déclaration de conflit d'intérêts
CONFLICT OF INTEREST The authors declare no conflict of interest.
Références
Pharm Pract (Granada). 2017 Jan-Mar;15(1):827
pubmed: 28503216
BMJ. 2016 Feb 29;352:i1202
pubmed: 26926703
Health Policy. 2006 Jul;77(2):166-71
pubmed: 16095749
Lancet Glob Health. 2017 Nov;5(11):e1075-e1076
pubmed: 29025629
BMJ. 2012 Apr 03;344:e1567
pubmed: 22491075
PLoS One. 2019 Feb 28;14(2):e0212875
pubmed: 30818373
Lancet Infect Dis. 2014 Aug;14(8):742-750
pubmed: 25022435
Infect Drug Resist. 2009;2:1-11
pubmed: 21694883
BMC Public Health. 2019 Oct 15;19(1):1292
pubmed: 31615486
J Clin Pharm Ther. 2012 Jun;37(3):308-12
pubmed: 21883328
Lancet Infect Dis. 2013 Dec;13(12):1057-98
pubmed: 24252483
Risk Manag Healthc Policy. 2014 Feb 20;7:35-44
pubmed: 24591853
BMC Infect Dis. 2011 Apr 20;11:99
pubmed: 21507212
PLoS One. 2013 Dec 23;8(12):e84177
pubmed: 24376793
Pharm Pract (Granada). 2018 Apr-Jun;16(2):1172
pubmed: 30023027
Health Policy Plan. 2016 Mar 8;31(7):940-953
pubmed: 26962123
BMC Public Health. 2017 Oct 10;17(1):799
pubmed: 29017473
Antibiotics (Basel). 2017 Oct 31;6(4):
pubmed: 29088074
Health Aff (Millwood). 2012 Dec;31(12):2774-84
pubmed: 23213162
Int J Qual Health Care. 2007 Dec;19(6):349-57
pubmed: 17872937
Health Expect. 2014 Oct;17(5):651-63
pubmed: 22583645
Patient Educ Couns. 2008 Oct;73(1):146-52
pubmed: 18640805
Trop Med Int Health. 2014 Jul;19(7):761-8
pubmed: 24750565
BMC Public Health. 2017 Apr 19;17(1):333
pubmed: 28420365
Lancet. 2011 Jan 15;377(9761):228-41
pubmed: 21146207
PLoS Med. 2009 Jun 2;6(6):e1000084
pubmed: 19492093
Int J Antimicrob Agents. 2018 Dec;52(6):771-782
pubmed: 30312654
BMJ Open. 2017 Mar 2;7(3):e013190
pubmed: 28255093
PLoS One. 2020 Jan 16;15(1):e0227973
pubmed: 31945117
BMJ. 2010 May 18;340:c2096
pubmed: 20483949
Ups J Med Sci. 2014 May;119(2):125-33
pubmed: 24735112
BMJ. 2015 Sep 30;351:h5195
pubmed: 26423832
Indian J Pharmacol. 2016 Jul-Aug;48(4):365-371
pubmed: 27756945
Pharm Pract (Granada). 2019 Jul-Sep;17(3):1540
pubmed: 31592295
Indian J Pharmacol. 2017 Nov-Dec;49(6):419-431
pubmed: 29674796
PLoS One. 2019 Jun 27;14(6):e0219002
pubmed: 31247028
Emerg Infect Dis. 2006 Mar;12(3):452-9
pubmed: 16704784
PLoS One. 2012;7(7):e41314
pubmed: 22911779